Botanical species · safety record

Rumex acetosa

The EFSA Compendium of Botanicals holds 17 constituent measurements and 1 adverse-effect record for Rumex acetosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rumex acetosa L.

17Constituent measurements
1Safety records
6Cited sources
13Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 13 licensed products naming Rumex acetosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Aerial parts
  • Flower
  • Leaf
  • Leaf/Leaves
  • Leaves
  • Rumex acetosa - whole plant
  • Stem(s)

What the records describe

Constituents measured

  • Anthracene derivatives3
  • Chrysophanol2
  • Emodin2
  • Physcion2
  • Aloe-emodin1
  • Aloin a1
  • Anthraquinones1
  • Nepodin1
  • Oxalic acid1
  • Rhein1

Plant parts

  • Live plants8
  • Aerial part of plants4
  • Unspecified2
  • Fruit unspecified1
  • Leaves1
  • Roots and other underground parts1
  • Stem1
  • stalk1

Preparations

  • Solvent extraction15

Effect types

  • Systemic1

Target tissues

  • Neurologic1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AnthraquinonesAerial part of plantsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
ChrysophanolAerial part of plantsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
EmodinAerial part of plantsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
Oxalic acidUnspecified3000 ppmResolve DOI
PhyscionAerial part of plantsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
Aloe-emodinLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Aloin aLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Anthracene derivativesFruit unspecifiedSolvent extraction0.83 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Anthracene derivativesLeavesSolvent extraction1.59 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Anthracene derivativesRoots and other underground partsSolvent extraction3.76 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ChrysophanolLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
EmodinLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
NepodinUnspecifiedUnspecifiedNo resolvable identifier
PhyscionLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
RheinLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Sennoside aLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Sennoside bLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicNeurologicStem / stalkHuman (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Wegiera, Magdalena., Smolarz, Helena D., Wianowska, Dorota., Dawidowicz, Andrzej L. Anthracene derivatives in some species of Rumex L. genus. Acta societatis botanicorum poloniae, 2007, vol. 76, no. 2, p. 103-108.
  2. Mithril, Charlotte., Dragsted, Lars Ove. Safety evaluation of some wild plants in the New Nordic Diet. Food and chemical toxicology, 2012, vol. 50, no. 12, p. 4461-4467. DOI
  3. Lee, NJ., Choi, JH., Koo, BS., Ryu, SY., Han, YH., Lee, SI., Lee, DU. Antimutagenicity and cytotoxicity of the constituents from the aerial parts of Rumex acetosa . Biological & pharmaceutical bulletin, 2005, vol. 28, no. 11, p. 2158-2161. DOI
  4. Hsiao, Pei-Ken., Ho, Li-I., Chen, Pi-Chu., Kuo, Hang-Chou. Botanical and chemical studies of Chinese herbal medicine Yangti. Yaoxue tongbao, 1980, vol. 15, no. 7, p. 48.
  5. Suckling, C.W. The recent case of poisoning by common sorrel (rumex acetosa). British medical journal, 1886, vol. 2, no. 1339, p. 436. DOI
  6. Sharma, Mrs. Manju., Rangaswami, S. Chemical components of the roots of Rumex acetosa: isolation of omega-acetoxyaloe emodin, a new 1,8-dihydroxyanthraquinone derivative. Indian journal of chemistry, section b: organic chemistry including medicinal chemistry, 1977, vol. 15B, no. 10, p. 884-5.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue